Graves' disease, the leading cause of hyperthyroidism in the UK, affects multiple body systems including sexual health. Whilst more common in women, men with Graves' disease may experience erectile dysfunction (ED) alongside classic symptoms such as weight loss, tremor, and palpitations. The connection between thyroid disorders and male sexual function is increasingly recognised but often under-discussed. Excess thyroid hormones disrupt testosterone levels, vascular function, and psychological wellbeing—all essential for normal erections. Importantly, erectile difficulties associated with Graves' disease are often reversible with appropriate treatment. Men experiencing ED alongside hyperthyroid symptoms should consult their GP, as timely diagnosis and management can restore both thyroid function and sexual health.

Understanding Graves' Disease and Sexual Health

Graves' disease is an autoimmune condition and the most common cause of hyperthyroidism (overactive thyroid) in the United Kingdom. Hyperthyroidism affects approximately 2% of women and 0.2% of men, with Graves' disease being responsible for 60-80% of these cases. In this condition, the immune system produces antibodies that stimulate the thyroid gland to produce excessive amounts of thyroid hormones—primarily thyroxine (T4) and triiodothyronine (T3). These hormones regulate metabolism, energy production, and numerous bodily functions, including the cardiovascular, nervous, and reproductive systems.

Whilst Graves' disease is more prevalent in women, men who develop the condition may experience a range of symptoms beyond the classic presentations of weight loss, tremor, heat intolerance, and palpitations. Sexual health concerns, including erectile dysfunction (ED), are increasingly recognised as important but often under-discussed manifestations of thyroid disorders in men. Erectile dysfunction—defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance—can significantly impact quality of life, relationships, and psychological wellbeing.

The relationship between thyroid function and male sexual health is complex and multifactorial. Thyroid hormones influence testosterone production, vascular function, neurological pathways, and psychological state—all of which are essential for normal erectile function. It's important to note that both hyperthyroidism and hypothyroidism (including that occurring after treatment) can affect sexual function. Understanding this connection is crucial for both patients and healthcare professionals, as effective management of the underlying thyroid disorder and restoration of normal thyroid function (euthyroidism) often leads to improvement in sexual function. Men experiencing erectile difficulties alongside symptoms suggestive of hyperthyroidism should discuss these concerns openly with their GP, as timely diagnosis and treatment can address both the endocrine disorder and its impact on sexual health.

Can Graves' Disease Cause Erectile Dysfunction?

Yes, there is a recognised clinical association between Graves' disease and erectile dysfunction in men. Research indicates that hyperthyroidism, including that caused by Graves' disease, can contribute to erectile difficulties through several interconnected mechanisms. Studies suggest that men with untreated or poorly controlled hyperthyroidism experience higher rates of erectile dysfunction compared to the general population, though prevalence estimates vary considerably between studies.

The link between Graves' disease and ED is primarily mediated through the effects of excess thyroid hormones on the male reproductive system. Hyperthyroidism disrupts the hypothalamic-pituitary-gonadal axis, leading to alterations in sex hormone levels. Specifically, elevated thyroid hormones increase the production of sex hormone-binding globulin (SHBG) in the liver, which binds to testosterone and reduces the amount of free (biologically active) testosterone available in the bloodstream. Whilst total testosterone levels may appear normal or even elevated, the reduction in free testosterone can impair libido and erectile function.

Additionally, the cardiovascular effects of hyperthyroidism—including increased heart rate, elevated blood pressure, and potential arrhythmias—may contribute to erectile dysfunction. The psychological burden of living with a chronic autoimmune condition, combined with symptoms such as anxiety, irritability, and sleep disturbance commonly seen in Graves' disease, can further impact sexual function.

It is worth noting that hyperthyroidism is also associated with ejaculatory disorders, particularly premature ejaculation, while hypothyroidism more commonly presents with reduced libido and erectile dysfunction.

Importantly, erectile dysfunction in men with Graves' disease is often reversible with appropriate treatment of the underlying thyroid disorder. Normalisation of thyroid hormone levels through antithyroid medication, radioiodine therapy, or surgery typically leads to improvement in sexual function, though the timeframe for recovery varies between individuals and may take several months after achieving stable thyroid function.

How Thyroid Hormones Affect Male Sexual Function

Thyroid hormones exert profound effects on multiple physiological systems that are integral to male sexual function. Understanding these mechanisms helps explain why thyroid disorders, particularly hyperthyroidism, can lead to erectile dysfunction and other sexual health concerns.

Hormonal regulation is perhaps the most direct pathway. Excess thyroid hormones stimulate hepatic production of sex hormone-binding globulin (SHBG), which binds circulating testosterone with high affinity. This results in decreased free testosterone—the fraction that can enter cells and exert biological effects. Reduced free testosterone impairs libido (sexual desire) and can directly affect erectile function. Some research suggests that hyperthyroidism may also affect the conversion of testosterone to oestradiol, potentially leading to hormonal imbalances that can further impact sexual function.

Vascular function is critically important for erectile function, as erections depend on adequate blood flow to the corpora cavernosa of the penis. Hyperthyroidism causes a hyperdynamic circulatory state with increased cardiac output, tachycardia, and systolic hypertension. These cardiovascular changes may potentially affect the vascular responses required for normal erectile function, though the exact mechanisms in humans require further research.

Neurological and psychological factors also play significant roles. Thyroid hormones influence neurotransmitter systems, including dopamine and serotonin, which regulate sexual desire and arousal. The hypermetabolic state of Graves' disease commonly produces anxiety, restlessness, emotional lability, and sleep disturbance—all of which can diminish sexual interest and performance. Furthermore, the chronic stress of managing an autoimmune condition may contribute to psychological erectile dysfunction independent of the direct hormonal effects.

It's important to note that sexual dysfunction patterns differ between thyroid disorders—hyperthyroidism is often associated with premature ejaculation and erectile difficulties, while hypothyroidism more commonly presents with reduced libido and erectile dysfunction. Additionally, other factors such as comorbidities (diabetes, cardiovascular disease), medications (antidepressants, antihypertensives), and lifestyle factors (smoking, alcohol) may contribute to sexual dysfunction in men with thyroid disorders.

Treatment Options for Erectile Dysfunction in Graves' Disease

The cornerstone of managing erectile dysfunction in men with Graves' disease is effective treatment of the underlying hyperthyroidism. In many cases, restoration of normal thyroid function (euthyroidism) leads to significant improvement or complete resolution of erectile difficulties, though this may take several months following normalisation of thyroid hormone levels.

Beta-blockers such as propranolol are often prescribed for symptomatic relief of hyperthyroidism while awaiting the effects of definitive treatment. These medications can help control palpitations, tremor, and anxiety, potentially improving quality of life and sexual function in the interim.

Antithyroid medications such as carbimazole (or its active metabolite methimazole) are typically the first-line treatment for Graves' disease in the UK. These drugs inhibit thyroid hormone synthesis by blocking thyroid peroxidase, the enzyme responsible for incorporating iodine into thyroid hormones. Most patients achieve biochemical control within 4–8 weeks, with corresponding improvement in symptoms including sexual function. Treatment is usually continued for 12–18 months, after which approximately 50% of patients achieve remission.

Important safety information: Patients taking antithyroid medications should be aware of the rare but serious risk of agranulocytosis (severe reduction in white blood cells). If you develop a fever, sore throat, or mouth ulcers while taking carbimazole or propylthiouracil (PTU), stop the medication immediately and seek urgent medical assessment. Regular blood tests are required to monitor thyroid function and check for side effects. PTU, an alternative antithyroid drug, carries a risk of liver damage and requires liver function monitoring.

Radioiodine therapy (I-131) offers a definitive treatment option, particularly for patients who do not achieve remission with medication or experience adverse effects. The radioactive iodine is selectively taken up by thyroid tissue, leading to gradual destruction of the overactive gland. Whilst highly effective, this treatment commonly results in hypothyroidism, requiring lifelong thyroid hormone replacement with levothyroxine. Radioiodine is contraindicated in pregnancy and breastfeeding, and appropriate contraception is advised for at least 6 months for women and 4 months for men after treatment. Patients with active thyroid eye disease may require steroid prophylaxis, as radioiodine can worsen this condition, particularly in smokers.

Surgical thyroidectomy (total or near-total removal of the thyroid gland) may be recommended for patients with large goitres, compressive symptoms, or those who prefer definitive treatment. As with radioiodine, subsequent hypothyroidism requires levothyroxine replacement. Surgery carries risks including hypocalcaemia and recurrent laryngeal nerve injury, so referral to an experienced endocrine surgeon is important.

For persistent erectile dysfunction despite normalised thyroid function, additional interventions may be appropriate:

• Phosphodiesterase-5 (PDE5) inhibitors such as sildenafil, tadalafil, or vardenafil are first-line pharmacological treatments for ED. These medications enhance nitric oxide-mediated vasodilation in penile tissue, facilitating erections in response to sexual stimulation. They are contraindicated in patients taking nitrate medications or riociguat, and caution is needed with alpha-blockers. A cardiovascular risk assessment should be performed before prescribing these medications.

• Other ED treatments include vacuum erection devices and alprostadil (available as urethral suppositories or injectable therapy), which may be considered if PDE5 inhibitors are contraindicated or ineffective.

• Lifestyle modifications including regular exercise, smoking cessation (particularly important for those with thyroid eye disease), moderation of alcohol intake, and stress management can improve both thyroid control and erectile function.

• Psychological support or psychosexual counselling may benefit men whose erectile difficulties have a significant psychological component or have persisted despite medical treatment.

• Testosterone replacement therapy is occasionally considered if free testosterone remains low after thyroid normalisation, though this requires careful assessment and monitoring by an endocrinologist.

Patients and healthcare professionals should report suspected side effects to the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).

When to Seek Medical Advice

Men experiencing erectile dysfunction alongside symptoms suggestive of hyperthyroidism should seek medical evaluation promptly. Early diagnosis and treatment of Graves' disease not only improves sexual function but also prevents potentially serious complications of untreated hyperthyroidism, including atrial fibrillation, osteoporosis, and thyroid storm (a life-threatening hypermetabolic crisis).

Contact your GP if you experience:

• Persistent difficulty achieving or maintaining erections, particularly if this represents a change from your usual function

• Symptoms of hyperthyroidism such as unintentional weight loss, heat intolerance, tremor, palpitations, increased sweating, or anxiety

• A visible swelling in the neck (goitre) or eye symptoms such as grittiness, redness, swelling or bulging eyes (thyroid eye disease)

• Reduced libido or other changes in sexual function

• Symptoms affecting your quality of life or relationships

Your GP will typically arrange blood tests to assess thyroid function, including thyroid-stimulating hormone (TSH), free T4, and free T3 levels. If Graves' disease is suspected, thyroid receptor antibodies (TRAb) may be measured to confirm the autoimmune aetiology. Initial investigations may also include full blood count, liver function tests, and an ECG if palpitations or arrhythmia are suspected. Referral to an endocrinologist is usually recommended for confirmed Graves' disease, significant thyroid eye disease, pregnancy, cardiac complications, or when considering definitive treatment options.

If you are taking antithyroid medication (carbimazole or propylthiouracil) and develop fever, sore throat, or mouth ulcers, stop the medication immediately and seek urgent medical assessment as these may indicate agranulocytosis, a rare but serious side effect.

Seek urgent medical attention (contact 111 or attend A&E) if you develop:

• Severe palpitations or chest pain

• Acute confusion or altered consciousness

• Severe agitation or fever

• Sudden worsening of symptoms

These may indicate thyroid storm or other serious complications requiring immediate treatment.

It is important to discuss sexual health concerns openly with healthcare professionals. Erectile dysfunction is a common and treatable condition, and addressing it as part of comprehensive management of Graves' disease can significantly improve quality of life. Do not delay seeking help due to embarrassment—GPs are accustomed to discussing sexual health and can provide appropriate investigation, treatment, or specialist referral. For persistent erectile dysfunction despite achieving normal thyroid function, referral to urology, andrology, or psychosexual services may be considered.

With effective management of the underlying thyroid disorder and, if necessary, specific treatment for erectile dysfunction, most men experience substantial improvement in sexual function.

Frequently Asked Questions